Kim Eun-Kyoung, Kleman Amy M, Ronnett Gabriele V
Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Neurosci Lett. 2007 Aug 23;423(3):200-4. doi: 10.1016/j.neulet.2007.06.056. Epub 2007 Aug 6.
Understanding the mechanisms that regulate feeding is critical to the development of therapeutic interventions for obesity. Many studies indicate that enzymes within fatty acid metabolic pathways may serve as targets for pharmacological tools to treat this epidemic. We, and others have previously demonstrated that C75, a fatty acid synthase (FAS) inhibitor, induced significant anorexia and weight loss by both central and peripheral mechanisms. Because the hypothalamus is important in the regulation of homeostatic processes for feeding control, we have identified pathways that alter the gene expression of FAS in primary hypothalamic neuronal cultures. Insulin, glucose and AICAR (an activator of AMP-activated protein kinase) affected changes in hypothalamic FAS mRNA, which may be regulated via the SREBP1c dependent or independent pathway.
了解调节进食的机制对于开发肥胖症治疗干预措施至关重要。许多研究表明,脂肪酸代谢途径中的酶可能成为治疗这一流行病的药理学工具的靶点。我们和其他人之前已经证明,脂肪酸合酶(FAS)抑制剂C75通过中枢和外周机制诱导显著的厌食和体重减轻。由于下丘脑在调节进食控制的稳态过程中很重要,我们已经确定了在原代下丘脑神经元培养物中改变FAS基因表达的途径。胰岛素、葡萄糖和AICAR(一种AMP激活蛋白激酶激活剂)影响下丘脑FAS mRNA的变化,这可能通过SREBP1c依赖性或非依赖性途径进行调节。